← Back to Search

Iron Supplement

Iron Supplementation for Hypoxia

Phase < 1
Waitlist Available
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 - 60
For women, premenopausal status
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 hour
Awards & highlights

Study Summary

This trial will test whether iron pills can help people exercise better in low-oxygen conditions.

Who is the study for?
This trial is for premenopausal women aged 18-60 who are not heavily involved in athletic training, do not use heart or lung medications, have not taken iron supplements recently, and don't have anemia or other health conditions that affect exercise ability. They should also not be pregnant or living at high altitudes.Check my eligibility
What is being tested?
The study tests if taking ferrous sulfate (iron) pills can improve how well participants perform physical activities when there's less oxygen available, like at high altitudes.See study design
What are the potential side effects?
Iron supplements like ferrous sulfate may cause stomach upset, constipation, diarrhea, nausea and dark stools. More serious side effects are rare but can include allergic reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 60 years old.
Select...
I am a woman and have not gone through menopause.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 hour for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Maximal oxygen uptake
Maximum workload
Secondary outcome measures
Oxygen saturation at peak exercise
Pulmonary artery systolic pressure measured by echocardiography
Submaximal Stage 1 workload
+3 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Healthy individuals - post-ironActive Control1 Intervention
The same five healthy participants will complete echocardiography and exercise testing after taking 30 days of oral iron supplementation.
Group II: Healthy individuals - pre-ironPlacebo Group1 Intervention
Five healthy participants will be enrolled. Baseline echocardiography and exercise data prior to oral iron supplementation will be obtained as part of the "parent" study to this study (NCT05272514).

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,726 Previous Clinical Trials
2,141,671 Total Patients Enrolled
7 Trials studying Hypoxia
518 Patients Enrolled for Hypoxia

Media Library

Ferrous sulfate 325mg (Iron Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05349630 — Phase < 1
Hypoxia Research Study Groups: Healthy individuals - pre-iron, Healthy individuals - post-iron
Hypoxia Clinical Trial 2023: Ferrous sulfate 325mg Highlights & Side Effects. Trial Name: NCT05349630 — Phase < 1
Ferrous sulfate 325mg (Iron Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05349630 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to take part in this medical experiment?

"In this study, five individuals who have suffered anoxia can partake and must be between 18-60 years old. Special consideration is given to premenopausal women."

Answered by AI

Does this research study accept participants of a younger age demographic?

"In order to meet the prerequisites for this medical trial, patient must be between 18 and 60 years old."

Answered by AI

Are there still available slots to participate in this trial?

"Affirmative, the information housed on clinicaltrials.gov indicates that this medical trial is currently recruiting potential participants. This study was initially made public on January 1st 2023 and has been revised most recently in September 6th 2022. There are 5 openings across a single location."

Answered by AI

What is the primary objective of this clinical exploration?

"This medical trial will track a variety of metrics to determine efficacy and safety, with the primary measure being maximal oxygen uptake over an hour-long period. Secondary outcomes include pulmonary artery systolic pressure (measured in mmHg), submaximal Stage 2 workload (in Watts at 60% x hypoxic VO2max during baseline test) and tricuspid annular plane systolic excursion (also measured in mm)."

Answered by AI

Are there any limitations to the number of participants enrolled in this research project?

"That is correct. According to information available on clinicaltrials.gov, this medical study opened its recruitment portal on January 1st of 2023 and recently updated their parameters in September 6th 2022. They are currently searching for 5 participants across a single site."

Answered by AI
Recent research and studies
~3 spots leftby Aug 2024